Publications by authors named "Michael T Nurmohamed"

Claim this Profile
E
Endothelial cell dysfunction in RA: biomarkers IL-8, E-selectin, VCAM-1 and MCP-1 correlated with PET/CT.
Bas Dijkshoorn, Geoffrey W de Mooij, Annelies B Blanken, Calin D Popa, Michael T Nurmohamed

Rheumatology (Oxford)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial.
Maike H M Wientjes, Sadaf Atiqi, Gerrit J Wolbink, Michael T Nurmohamed, Maarten Boers

Ann Rheum Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritis.
Tilia Selldén, Kerstin Andersson, Inger Gjertsson, Anna-Karin Hultgård Ekwall, Kristina Lend, Michael T Nurmohamed

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic Effects of Apremilast in Patients With Psoriatic Arthritis: A Prospective Cohort Study.
Romy Hansildaar, Eva H van Geel, Fatih Çoban, Bas Dijkshoorn, Maaike Heslinga, Michael T Nurmohamed

J Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial.
Kristina Lend, Jos Wr Twisk, Nupur Kumar, Bas Dijkshoorn, Jon Lampa, Michael T Nurmohamed

RMD Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F van Vollenhoven, Rosemary J Hollick

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteome analysis of rheumatic patients reveals differences in fingerprints based on cardiovascular history: a pilot study.
Romy Hansildaar, Max van Velzen, Eduard W J van der Vossen, Gertjan Kramer, Michael T Nurmohamed

Proteome Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Baseline CXCR3Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis.
Julia M Scheffler, Christina Drevinge, Catharina Lindholm, Inger Gjertsson, Kristina Lend, Michael T Nurmohamed

ACR Open Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.
Bas Dijkshoorn, Romy Hansildaar, Daisy Vedder, Nida Soutari, Anna Rudin, Michael T Nurmohamed

RMD Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial.
Kristina Lend, Jon Lampa, Leonid Padyukov, Merete Lund Hetland, Marte Schrumpf Heiberg, Michael T Nurmohamed

Ann Rheum Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Adding Single-Nucleotide Polymorphisms to Risk Algorithms Improve Cardiovascular Disease Risk Prediction in Rheumatoid Arthritis? An Internal and External Validation of a Clinical Risk Score.
Rabia Agca, Calin D Popa, Martijn W Heymans, Bart Crusius, Alexandre E Voskuyl, Michael T Nurmohamed

Arthritis Care Res (Hoboken)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
Reinder Raadsen, Bas Dijkshoorn, Laurette van Boheemen, Edwin Ten Boekel, Arno W R van Kuijk, Michael T Nurmohamed

Joint Bone Spine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation and clearance of TNF-TNF inhibitor complexes during TNF inhibitor treatment.
Lea Catharina Berkhout, Merel Jeanne I'Ami, Simone Kruithof, Erik Hans Vogelzang, Femke Hooijberg, Michael Twahier Nurmohamed

Br J Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comments on "Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women" by Koet.
Reinder Raadsen, Romy Hansildaar, Arno W R van Kuijk, Michael T Nurmohamed

Semin Arthritis Rheum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study.
Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Michael T Nurmohamed

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology.
Yaëlle R Besten, Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Sadaf Atiqi, Michael T Nurmohamed

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correlation between 4 adherence measurements methods in patients with rheumatoid arthritis using methotrexate.
Renske C F Hebing, Nada Elhendy, Eva H van Geel, Milou van Heuckelum, Michael T Nurmohamed

Br J Clin Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature.
Eva Vermeer, Renske C F Hebing, Maartje M van de Meeberg, Marry Lin, Tim G J de Meij, Michael T Nurmohamed

Curr Rheumatol Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated.
Reinder Raadsen, Romy Hansildaar, Lianne C Pouw, Femke Hooijberg, Laura Boekel, Michael T Nurmohamed

RMD Open· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT.
Bart F Seppen, Marjolein J E Greuter, Jimmy Wiegel, Marieke M Ter Wee, Maarten Boers, Michael T Nurmohamed

Rheumatology (Oxford)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Mikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Michael T Nurmohamed

Ann Rheum Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?
Daisy Vedder, Maaike Heslinga, Carla A Wijbrandts, Michael T Nurmohamed, Martijn Gerritsen

Clin Exp Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years.
Ingrid M Visman, Sadaf Atiqi, Maarten Boers, Jos W R Twisk, Michael T Nurmohamed

J Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor.
Jette A van Lint, Naomi T Jessurun, Sander W Tas, Harald E Vonkeman, Martijn B A van Doorn, Michael T Nurmohamed

BioDrugs· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study.
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Michael T Nurmohamed

Arthritis Res Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis